Two cardiologists discuss the issue of discontinuation or downtitration of RAASi therapy when hyperkalemia occurs in HF patients and the potential of novel potassium binders in these patients.
Iron deficiency is very common in HF patients, also in patients who are nonanemic. Therefore, you need to measure it and treat it, conclude Robert Mentz and Peter van der Meer.
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals